Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Self-Assessment Questions
Past Issue Archives
Site Map
Information for
Advertisers
Physicians/
Clinicians
Health Care
Managers
Medical
Educators

Hospital Physician
JCOM
Seminars in
Medical Practice
Board Review Manuals








Click here for your free
Oncology iPhone and iPad Apps


Click here for your free
Oncology Android App


Click here for your free
Oncology Kindle Fire App







BACK ISSUES

Oncology
Volume 11, Part 4
Chronic Myeloid Leukemia


Contributors:
Kathryn E. Beckerman, MD, PhD

Clinical Fellow,
Division of Hematology/Oncology,
Vanderbilt-Ingram Cancer Center,
Vanderbilt University
School of Medicine,
Nashville, TN

Michael R. Savona, MD
Associate Professor,
Division of Hematology/Oncology,
Vanderbilt-Ingram Cancer Center,
Vanderbilt University
School of Medicine,
Nashville, TN


Table of Contents:
• Introduction
• Pathophysiology
• Epidemiology
• Clinical Features and Diagnosis
• Tyrosine Kinase Inhibitors in CML
• Monitoring Response to TKI Therapy
• Allogeneic Stem Cell Transplant
• Conclusion
• Board Review Questions
• References


Board Exam information for
ONCOLOGY
510 Walnut St, Suite 1700, Phila, PA 19106-3699 (215) 446-3500



Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2015, Turner White Communications
Updated 6/26/15 • jdw